Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 153,447 | 163,615 | 173,197 | 164,029 | 327,545 |
| Marketable Securities | 10,551 | N/A | 3,964 | N/A | N/A |
| Receivables | 40,448 | 42,481 | 41,461 | 40,309 | 31,864 |
| Inventories | 14,600 | 12,372 | 11,225 | 9,824 | 6,674 |
| TOTAL | $235,045 | $238,483 | $243,102 | $229,308 | $371,346 |
| Non-Current Assets | |||||
| PPE Net | 17,188 | 16,299 | 15,098 | 14,868 | 11,813 |
| Intangibles | 874,407 | 900,596 | 910,635 | 923,794 | 627,464 |
| Other Non-Current Assets | 17,558 | 18,211 | 18,990 | 18,386 | 16,812 |
| TOTAL | $909,153 | $935,106 | $944,723 | $957,048 | $656,089 |
| Total Assets | $1,144,198 | $1,173,589 | $1,187,825 | $1,186,356 | $1,027,435 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,133 | 1,079 | 1,127 | N/A | N/A |
| Accounts payable and accrued liabilities | 10,328 | 11,273 | 12,360 | 11,201 | 8,472 |
| Accrued Expenses | 33,565 | 38,543 | 39,475 | 29,044 | 20,756 |
| Other current liabilities | 6,196 | 2,921 | 2,913 | 2,887 | 3,375 |
| TOTAL | $59,345 | $62,543 | $64,151 | $50,037 | $36,105 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,075 | 917 |
| Deferred Revenues | 4,193 | 4,878 | 4,646 | 3,440 | 566 |
| Other Non-Current Liabilities | 16,097 | 20,595 | 21,225 | 21,378 | 17,801 |
| TOTAL | $20,702 | $25,856 | $27,160 | $29,239 | $20,153 |
| Total Liabilities | $80,047 | $88,399 | $91,311 | $79,276 | $56,258 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 71,576 | 71,445 | 71,218 | 71,043 | 67,474 |
| Common Shares | 72 | 71 | 71 | 71 | 67 |
| Retained earnings | -381,150 | -371,618 | -357,157 | -346,629 | -332,500 |
| Other shareholders' equity | -38,050 | -20,681 | -15,083 | -8,140 | 0 |
| TOTAL | $1,064,151 | $1,085,190 | $1,096,514 | $1,107,080 | $971,177 |
| Total Liabilities And Equity | $1,144,198 | $1,173,589 | $1,187,825 | $1,186,356 | $1,027,435 |